Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
"The story says that the average copayment for a month's supply of some of the topical NSAID medications is around $30. It would have been nice to include the cost of comparable oral medications. Although the story explains the available evidence comparing topical NSAIDs to oral pain relievers, highlights the limited number of direct comparisons, and carefully states the general consensus of experts, all of this solid reporting is undermined by a focus on personal anecdotal evidence over quantifiable benefits. Indeed, the reporter claims one medication provided immediate relief, a statement at odds with clinical trials that conclude that it usually takes hours for patients to feel the pain-relief effects of topical NSAIDs. The story summarizes the reported side effects of topical NSAIDS. What's more, the reporter points out that the potential risks in people who have other health problems or are taking other drugs have not been well studied. That insight is something we see too rarely. The story refers to a number of clinical trials and systematic reviews of the evidence. It highlights areas where evidence is lacking or inconclusive. It would have been helpful to point out that in placebo-controlled trials, almost as many people who received the placebo reported pain relief as did those who got the active medication. The story could have mentioned that the systematic review it referred to was published by the Cochrane Collaboration and also the sources of the other clinical trial reports, so that interested readers could more easily locate the original articles. The story does not exaggerate the common pains these drugs are intended to treat, but the personal anecdotes and opinions highlighted at the beginning and ending of the story are unrepresentative of the typical experiences reported by participants in clinical trials and create a powerful impression that is at odds with the evidence. The story includes quotes from several experts and points out that two of them have accepted consulting fees or research support from pharmaceutical companies. The essence of this story is an attempt to compare topical NSAIDs with pills and other pain treatments. As noted above, though, the story does not mention that most people with minor pains feel better after awhile even if they don't take any pain relief medication. It also should have mentioned that the difference between placebo and active treatment groups in the clinical trials is often slim. The story reports that only three topical NSAIDs (nonsteroidal anti-inflammatory drugs) are approved for sale with a prescription in the United States, while several brands are sold over the counter in Europe. Part of the focus of the story is that NSAIDS have been around for a long time but only recently are being given a more serious scientific reassessment. As the story says, ""But a number of new controlled trials and meta-analyses like Dr. Moore's suggest that topical Nsaids are as effective as their oral counterparts for treating osteoarthritis in the knee and hand as well as musculoskeletal injuries like soreness and tendinitis."" The story includes several experts and mentions multiple studies."

Ex Output:
Topical Gel Catches Up With Pills for Relief

Ex Input:
The story provided several estimates for the cost of gastric banding; it also discussed insurance coverage, i.e. that the procedure was not always covered by insurance. While the story mentioned weight loss, health improvement, and longer life, it failed to provide quantitative estimates for these. The story provided quantitative information on the disease reduction obtained with the use of this device in individuals with type II diabetes. Although the story did mention that weight loss is slower with gastric banding than with gastric bypass, itfailed to provide quantitative information about the amount or rate of weight loss attained with banding. The story should also have mentioned that long-term followup finds for those whose diabetes resolves following gastric banding, about half re-develop diabetes at 10 years. The story mentioned weight regain as well as some of the side effects that occur with the use of this device. For a more complete discussion, it should have included information about how frequently these occur. When discussing the effect of gastric banding on type II diabetes, the story mentioned the research about the use of this device for this population. It mentioned the evidence about safety and effectiveness and where it had been published. As for the impact of the banding procedure on weight, the story neglected to include information on the average weight loss seen but did include several patient anecdotes. However the story was more focused on the marketing strategies for this device rather than the health claims per se. The story did not engage in disease mongering. The story included primary quotes from clinicians, industry spokespersons, and individuals who had undergone gastric banding. The story included a pretty comprehensive comparison between gastric banding and gastric bypass, another type of weight loss surgery. It only mentioned diet and exercise in passing and failed to mention medication that can be used for weight loss. The story provided a very complete discussion about the various venues at which gastric banding was available. The story provided a pretty complete history of the use of gastric banding. Does not rely on a press release

Ex Output:
Industry Giants Push Obesity Surgery

Ex Input:
Doctors' letters provided to The Associated Press give glowing medical marks to both men. The AP requested the results of a post-primary physical and, for each, a list of any major health conditions or prescription medications. Neither has any medical problems to speak of. The two have been engaged in one of the year's most expensive and closely watched Senate contests though outside groups on both sides have begun pulling money from the race as Strickland fails to gain traction against Portman's well-funded effort. The 60-year-old Portman, the Republican incumbent, is an avid sportsman who kayaks and cycles. He's on no medications and has no illnesses or chronic conditions. Strickland, Ohio's Democratic former governor, takes blood-pressure medicine. His doctor reports the 75-year-old has no illnesses or chronic conditions. Strickland would be the oldest person elected to a first term in the Senate though he'd be far from the oldest in the chamber. Thirteen sitting senators are 75 or older. That includes eight who are 80 and above. The median age in the Senate is around 63. When questioned about his age, Strickland says longevity runs in his family. The Portman campaign provided a letter from the senator's longtime doctor, James Hochwalt in Cincinnati, drawn from a July physical. "To my knowledge, there is nothing in his medical history or current medical status that would interfere with his demanding schedule and commitments of United States Senator," Hochwalt wrote. Strickland's physician, Paul Dusseau in Hilliard, also saw the candidate in July. In addition to an exam and lab work, Dusseau wrote that he reviewed Strickland's "past medical history, family medical history, daily habits and activities, and health over the past year." Dusseau issued what he dubbed an "Excellent Report!" Green Party Senate candidate Joseph DeMare is also in excellent health. His doctor, Matt Roth of Maumee, says in a letter provided to the AP that the 54-year-old takes no medication and has no ongoing medical concerns.

Ex Output:
Health reports rosy in Ohio's otherwise ugly US Senate race.